Raymond James & Associates’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $4.65M | Sell |
25,502
-1,625
| -6% | -$241K | ﹤0.01% | 1700 |
|
|
2024
Q2 | $3.22M | Sell |
27,127
-486
| -2% | -$51.1K | ﹤0.01% | 1874 |
|
|
2024
Q1 | $2.96M | Buy |
27,613
+7,146
| +35% | +$711K | ﹤0.01% | 1917 |
|
|
2023
Q4 | $2.04M | Sell |
20,467
-17,253
| -46% | -$1.69M | ﹤0.01% | 2089 |
|
|
2023
Q3 | $4.49M | Buy |
37,720
+11,256
| +43% | +$1.68M | ﹤0.01% | 1529 |
|
|
2023
Q2 | $4.72M | Sell |
26,464
-38,730
| -59% | -$7.11M | ﹤0.01% | 1519 |
|
|
2023
Q1 | $10.8M | Sell |
65,194
-30,377
| -32% | -$5.23M | 0.01% | 985 |
|
|
2022
Q4 | $15.1M | Sell |
95,571
-4,610
| -5% | -$702K | 0.01% | 795 |
|
|
2022
Q3 | $15.1M | Buy |
100,181
+23,679
| +31% | +$3.94M | 0.02% | 745 |
|
|
2022
Q2 | $12.6M | Buy |
76,502
+35,338
| +86% | +$6.8M | 0.01% | 846 |
|
|
2022
Q1 | $9.16M | Buy |
41,164
+2,754
| +7% | +$617K | 0.01% | 1117 |
|
|
2021
Q4 | $9.12M | Sell |
38,410
-46,715
| -55% | -$10.9M | 0.01% | 1154 |
|
|
2021
Q3 | $19.9M | Sell |
85,125
-12,598
| -13% | -$2.64M | 0.02% | 709 |
|
|
2021
Q2 | $20.1M | Buy |
97,723
+21,919
| +29% | +$4.51M | 0.02% | 710 |
|
|
2021
Q1 | $15.6M | Buy |
75,804
+12,947
| +21% | +$2.73M | 0.02% | 784 |
|
|
2020
Q4 | $13.5M | Buy |
62,857
+12,794
| +26% | +$2.48M | 0.01% | 798 |
|
|
2020
Q3 | $9.15M | Sell |
50,063
-29,085
| -37% | -$5.48M | 0.01% | 909 |
|
|
2020
Q2 | $14.6M | Sell |
79,148
-5,281
| -6% | -$1.05M | 0.02% | 651 |
|
|
2020
Q1 | $17M | Sell |
84,429
-2,027
| -2% | -$390K | 0.03% | 514 |
|
|
2019
Q4 | $16.2M | Sell |
86,456
-32,656
| -27% | -$5.62M | 0.02% | 676 |
|
|
2019
Q3 | $19M | Buy |
119,112
+1,496
| +1% | +$298K | 0.03% | 566 |
|
|
2019
Q2 | $29.6M | Buy |
117,616
+1,080
| +0.9% | +$250K | 0.04% | 408 |
|
|
2019
Q1 | $27.9M | Buy |
116,536
+10,004
| +9% | +$2.4M | 0.04% | 406 |
|
|
2018
Q4 | $24.5M | Sell |
106,532
-12,629
| -11% | -$3.11M | 0.04% | 405 |
|
|
2018
Q3 | $33.7M | Buy |
119,161
+22,321
| +23% | +$6.54M | 0.05% | 344 |
|
|
2018
Q2 | $28.4M | Buy |
96,840
+160
| +0.2% | +$43.7K | 0.05% | 373 |
|
|
2018
Q1 | $24.4M | Buy |
96,680
+23,975
| +33% | +$5.63M | 0.04% | 402 |
|
|
2017
Q4 | $15.7M | Buy |
72,705
+27,811
| +62% | +$5.63M | 0.03% | 564 |
|
|
2017
Q3 | $8.34M | Buy |
44,894
+2,183
| +5% | +$381K | 0.02% | 837 |
|
|
2017
Q2 | $7.37M | Buy |
42,711
+836
| +2% | +$134K | 0.02% | 863 |
|
|
2017
Q1 | $6.39M | Buy |
41,875
+1,945
| +5% | +$284K | 0.01% | 906 |
|
|
2016
Q4 | $5.88M | Sell |
39,930
-12,034
| -23% | -$1.74M | 0.02% | 907 |
|
|
2016
Q3 | $6.57M | Sell |
51,964
-2,204
| -4% | -$266K | 0.02% | 812 |
|
|
2016
Q2 | $6.11M | Buy |
54,168
+106
| +0.2% | +$11K | 0.02% | 761 |
|
|
2016
Q1 | $5.63M | Sell |
54,062
-2,940
| -5% | -$281K | 0.02% | 771 |
|
|
2015
Q4 | $6.43M | Buy |
57,002
+19,558
| +52% | +$2.16M | 0.02% | 695 |
|
|
2015
Q3 | $4.1M | Buy |
37,444
+2,864
| +8% | +$306K | 0.02% | 840 |
|
|
2015
Q2 | $3.31M | Buy |
34,580
+378
| +1% | +$35.3K | 0.01% | 1042 |
|
|
2015
Q1 | $3.19M | Buy |
34,202
+5,000
| +17% | +$437K | 0.01% | 968 |
|
|
2014
Q4 | $2.39M | Sell |
29,202
-3,188
| -10% | -$244K | 0.01% | 1059 |
|
|
2014
Q3 | $2.08M | Buy |
+32,390
| New | +$1.98M | 0.01% | 1082 |
|
Other funds holding ICUI
Raymond James & Associates's ICUI Position: Q3 2024 in Review
Raymond James & Associates reduced its ICU Medical (ICUI) stake by 6% in Q3 2024, selling an estimated $241K and leaving 25,502 shares worth $4.65M. The position accounts for ﹤0.01% of the portfolio, ranked #1700.
Raymond James & Associates first reported a position in ICUI in Q3 2014 and has held it in 41 quarters since. The position peaked at $33.7M in Q3 2018. 289 funds tracked by Wall St. Rank hold ICUI as of Q3 2024.
- Raymond James & Associates held 25,502 shares of ICU Medical worth $4.65M as of Q3 2024.
- Raymond James & Associates sold 1,625 ICU Medical shares in Q3 2024, an estimated $241K.
- ICU Medical made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1700 holding.
- Raymond James & Associates first reported a position in ICU Medical in Q3 2014 and has held it in 41 quarters since.
- Raymond James & Associates's ICU Medical position peaked at $33.7M in Q3 2018.
- 289 funds tracked by Wall St. Rank held ICU Medical as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.